Anastrozole drug reduces breast cancer in high risk post-menopausal women
Taking the breast cancer drug anastrozole for five years reduced the chances of post-menopausal women at high risk of breast cancer developing the disease by 53% compared with women who took a placebo, according to a study published in the Lancet today.
Linear Mode
